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S1. Synthesis and characterization 
S1.1 Materials and characterization 
2,4-dihydroxy benzaldehyde, 1,3-dibromopropane, dimethylamine solution 40% in water and 
tert-butyl bromoacetate were purchased from Alfa Aesar (USA). Hydrazine monohydrate 
(N2H4.H2O), trimethylamine 45% aqueous solution in water and all proteins (Bovine serum 
albumin, Esterase, Fibrinogen, transferrin and β-galactosidase) were purchased from Sigma 
Aldrich (USA).  Trifluoroacetic acid (TFA) was purchased from TCI (Japan). Ethyl acetate 
(EtOAc) and hexane were obtained from SK Chemical (Korea). Potassium carbonate 
(K2CO3), potassium bicarbonate (KHCO3), sodium hydroxide (NaOH), sodium chloride 
(NaCl), and sodium sulfite anhydrous (Na2SO3) was obtained from Samchun pure chemical 
Co.,Ltd (Korea). HPLC grade of tetrahydrofuran (THF) and acetonitrile (ACN) were 
purchased from Burdick & Jackson Honeywell (USA). Dichloromethane (DCM) HPLC was 
purchased from Daejung Co.,Ltd (Korea). PBS 1X, pH 7.4 was obtained from Gibco, 
ThermoFisher SCIENTIFIC (USA)  
AIEgens (AIE 1-4) were characterized using 400MHz FT-NMR (Agilent Technologies) and 
MALDI-TOF/TOF (Bruker Ultraflex III) with MALDI matrix made of 50:50 
water/acetonitrile with 0.1% TFA and 2,5-dihydroxybenzoic acid (2,5-DHB). UV –vis 
spectroscopy (Jasco V-670 spectrophotometer), Fluorometer (Hitachi F-7000), Microplate 
reader (Molecular devices SpectraMax i3x)  
 
S1.2 Synthesis of AIEgens (AIE1-4) 
1) Synthesis of compound 2 
 
Compound 2 was synthesized by adding hydrazine monohydrate (90 µL, 1.81 mmol) 
into compound 1, 2,4-dih ydroxy benzaldehyde (0.5 g, 3.65 mmol) in 10 mL of 
methanol. The mixture was refluxed for 4 h at 75℃. The solution was cooled to room 
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temperature then yellow solid was formed which was isolated by filtration and dried 
over under vacuum. Yield (72%, 0.357 g)  (400 MHz, DMSO) 6.29 (2H, s), 6.37 
(2H, s), 7.39 (2H, s) 8.73 (2H, s), 10.13 (2H, s) and 11.38 (2H, s).  (400 MHz, 
DMSO) 102.91, 108.65, 110.71, 133.39, 161.11, 162.20 and 162.51 Calculated [M], 
C14H12N2O4, molecular weight: m/z calcd 272.26 ; measured 272.60   
 
2) Synthesis of AIE-1 
 
a. Synthesis of t-butyl-protected AIE molecule 
To synthesize AIE-1, compound 2 (500 mg, 1.836 mmol) and K2CO3 (507.6 mg, 
3.673 mmol) were dissolved in 10 mL of acetonitrile. After 30 min, t-butyl 
bromoacetate (542 µL, 3.673 mmol) was added dropwise into mixture. The reaction 
was refluxed at 60 ℃ for overnight. After finishing the reaction, the reaction was 
then cooled to room temperature. The reaction mixture was treated with water and 
extracted with ethyl acetate (EA). Organic layer was washed with brine solution. The 
organic layer was dried over Na2SO4 and concentrated in vacuo. Purification was 
done by silica flash column chromatography with hexane: EA = 4:1. Yield (21%, 187 
mg)  (400 MHz, DMSO) 1.46 (18H, s), 4.68 (4H, s), 6.43 (2H, s), 6.55 (2H, s), 
7.39 (2H, s) 7.52 (2H, s), 8.91 (2H, s).  (400 MHz, DMSO) 27.82, 65.59, 82.79, 
102.17, 107.28, 111.44, 133.58, 158.84, 161.76, 163.03, 167.42 
b. Deprotection of t-butyl group 
To synthesize AIE-1, boc-protected AIE molecules (244mg, 0.487 mmol) was 
dissolved in 5 mL of DCM. TFA (0.2 mL , excess amount) was added into boc-
protected AIE in DCM. The reaction was stirred at room temperature for 12 hours. 
After reaction, DCM and TFA were removed using rotary evaporator and dried using 
high vacuum pump. To make negatively charged AIE-1, 2 equivalent of NaOH was 
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added into water. Yield (180 mg, 95%)  (400 MHz, DMSO) 4.72 (4H, s), 6.48 
(2H, s), 6.65 (2H, s), 7.54 (2H, s), 8.93 (2H, s).  (400 MHz, DMSO) 64.88, 
102.18, 107.52, 112.22, 132.80, 159.09, 160.52, 162, and 170.08 Calculated [M]
-
, 
C18H14N2O8
2-
, molecular weight: m/z calcd 386.32 ; measured 386.03 
 
3) Synthesis of compound 3 
 
Compound 3 was synthesized through reference [1]. Compound 1, 2,4-dihydroxy 
benzaldehyde (2 g, 14.48 mmol) and potassium bicarbonate (KHCO3, 1.448 g, 14.48 
mmol) were dissolved in dry acetone and then 1,3-dibromopropane (1.47 mL, 14.48 
mmol) was added dropwise into mixture. The reaction was refluxed at 60 ℃ for 60 h. 
After the reaction, solvent was evaporated under pressure. 20 mL of water was added 
and extracted with 30 mL of chloroform for three times. The organic layer was dried 
over Na2SO4 and concentrated in vacuo. Purification was done by silica flash column 
chromatography with hexane: EA = 1:1. Yield (17%, 1.2 g)  (400 MHz, CDCl3) 
2.36 (4H, m), 3.57 (4H, t), 4.12 (4H, t), 6.48 (2H, s), 6.59 (2H, s), 7.48 (2H, s), 9.85 
(2H, s), and 11.50 (2H, s).   (400 MHz, CDCl3) 29.47, 31.90, 65.79, 101.27, 
108.50, 115.30, 135.30, 164.41, 165.81, 194.37. Calculated [M], C10H11BrO3, 
molecular weight: m/z calcd 259.10 ; measured 258.36 
 
4) Synthesis of compound 4 
 
Compound 4 was synthesized by adding hydrazine monohydrate (7.5 µL, 0.09 mmol) 
into compound 3 (92.6 mg, 0.18 mmol) in 3 mL of acetonitrile. The mixture was 
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refluxed for 12 h at 60 ℃. After the reaction, solvent was dried over under vacuum. 
Yield (91%, 168 mg)  (400 MHz, CDCl3) 2.34 (4H, m), 3.60 (4H, t), 4.15 (4H, t), 
6.53 (4H, s), 8.61 (2H, s), and 11.73 (2H, s).  (400 MHz, CDCl3) 29.65, 32.11, 
50.86, 65.52, 101.82, 107.72, 111.28, 133.52, 161.71, 162.80, 16.89 Calculated [M], 
C20H22Br2 N2O4, molecular weight: m/z calcd 514.21; measured 515.12 
 
 
5) Synthesis of AIE-2 
 
Compound 4 (20 mg, 0.039 mmol) and dimethylamine 40% solution in water (17 µL, 
0.155 mmol) in THF and water co-solvent was stirred and heated up to 60 ℃ for 
overnight. After the reaction, the solvent (THF and water) was unreacted 
trimethylamine removed by evaporation. The 16 mg (98%) of product AIE-3 was 
obtained.  (400 MHz, D2O) 1.98 (4H, m), 2.68 (4H, t), 4.13 (4H, t), 6.38 (4H, s), 
6.62 (4H, s), 7.16 (2H, s), and 7.85 (2H, s), 11.70 (2H, s).  (400 MHz, D2O) 22.44, 
52.84, 63.74, 64.60, 101.62, 107.58, 111.80, 133.88, 159.85, 161.87, 162.89 
Calculated [M]
+
, C26H40N4O4
2+
, molecular weight: m/z calcd 472.63; measured  
471.39 
 
6) Synthesis of AIE-3 
 
Compound 4 (20 mg, 0.039 mmol) and dimethylamine 40% solution in water (17 µL, 
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0.155 mmol) in 1 mL of THF and water co-solvent was stirred and heated up to 60 ℃ 
for overnight. After the reaction, the solvent (THF and water) and unreacted 
dimethylamine was removed by evaporation. The 16 mg (98%) of product AIE-3 was 
obtained.  (400 MHz, DMSO) 1.98 (4H, m), 2.68 (4H, t), 4.13 (4H, t), 6.53 (4H, 
s), 7.51 (2H, s), and 8.80 (2H, s).  (400 MHz, DMSO) 34.41, 42.99, 54.68, 65.55, 
101.82, 107.84, 112.01, 133.06, 160.84, 162.32, 162.73 Calculated [M], C24H34N4O4, 
molecular weight: m/z calcd 442.56; measured 443.32 
 
7) Synthesis of AIE-4 
 
Compound 4 (10 mg, 0.019 mmol) and sodium sulfite (NaSO3. 6 mg, 0.042 mmol) in 
2 mL of THF and water co-solvent was stirred and heated up to 100 ℃ under nitrogen 
atmosphere for overnight. After the reaction, the mixture kept at room temperature. 
Acetone (diethyl ether) was added to get white crystals. The 4 mg (80%) of product 
AIE-4 was obtained.  (400 MHz, D2O) 1.98 (4H, m), 2.68 (4H, t), 4.13 (4H, t), 
6.53 (4H, s), 7.51 (2H, s), and 8.80 (2H, s).  (400 MHz, D2O) 24.10, 47.67, 66.48, 
101.39, 107.51, 111.99, 133.25, 159.80, 162.05, 162.50 Calculated [M]
-
, 
C26H40N4O4
2--
, molecular weight: m/z calcd 514.52; measured; 514.42 
 
S2. Spectrometer experiment 
 
S2.1 Characterization of AIEgens (AIE 1-4) 
 
 S8
 
Figure S1. UV-Vis absorption spectra of (a) AIE-2, (b) AIE-3 and (c) AIE-4 in water (black 
line) and in a mixture of  /THF (v/v, 5:95) (red line).[AIEgens] = 40 µM 
 
 
Figure S2 Fluorescence spectra of (a) AIE-1, (b) AIE-2, (c) AIE-3, and (d) AIE-4 in gradual 
addition (0%, 30%, 60%, 90% and 95%) of THF to water.  	
= 365 nm [AIEgens] = 40 µM 
 
S2.2 Method for AIE fluorescence in presence of five proteins 
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Figure S3. Schematic illustration of fluorescence experiments with four AIEgens and five 
proteins 
All four AIEgens solution in water were prepared 42.1 uM stock solution using 3
rd
 distilled 
water. Also, five proteins were prepared 10 uM in 1X PBS pH 7.4. In individual 96 wells, 95 
uL of 42.1 uM AIE stock solution was added followed by addition 5 uL of 10 uM protein 
solutions. We measured fluorescence using microplate reader right after adding proteins.  
 
1 2 3 4 5 6
A
B
C
D
AIEgens
95 μL of 42.1 μM AIE-1 to 4
in each well
5 μL of 10 μM five proteins
Proteins
AIEgens
1 2 3 4 5 6
A
B
C
D
40 μM AIE-1 to 4 + 500 nM five proteins
in each well
 BSA Esterase transferrin fibrinogen β-galactosidase 
AIE-1 1.239416 1.056613 1.059014 0.818529 1.096484 
  1.216347 1.04249 1.092795 0.864261 1.073643 
 1.262054 1.037588 1.098455 0.873736 1.105933 
 1.233958 1.047265 1.082385 0.910473 1.218116 
 1.179534 1.018032 1.097318 0.929701 1.108485 
 1.33237 1.10467 1.112301 0.913101 1.11177 
AIE-2 0.95884 1.934575 1.039262 1.031855 1.290872 
 0.962982 1.896937 1.060973 1.024958 1.28009 
 0.936983 1.981135 1.10684 1.022423 1.271752 
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S3. Determination of the binding stoichiometry and binding constant 
Stoichiometry of the AIEgen-protein was determined by saturation point of fluorescence 
intensity with increasing AIEgens’ concentrations at fixed concentration of proteins. The 
fluorescence intensity was measured when protein concentration was fixed at 5 µM by 
increasing AIE-1 and AIE-2 from 0 to 64 µM. Normalized fluorescence intensity was 
calculated by deducting fluorescence intensity of only AIE-1 and AIE-2 solution from 0 to 64 
 0.951488 1.933937 1.076116 1.006586 1.263268 
 0.962325 1.887742 1.051304 0.99564 1.297167 
 0.926256 1.823174 1.069183 0.956779 1.239423 
AIE-3 1.100433 2.893602 1.246832 1.407829 1.900978 
 1.013874 2.760429 1.244907 1.300993 1.946048 
 1.192766 2.843424 1.340327 1.327254 1.987403 
 1.147104 2.941761 1.353363 1.287405 1.953862 
 1.116288 2.985459 1.274084 1.254207 2.022221 
 1.211556 2.812856 1.125703 1.235092 2.00545 
AIE-4 1.911631 1.699986 1.336614 1.206542 1.382391 
 1.952883 1.641435 1.299267 1.167729 1.344156 
 1.89577 1.62924 1.268687 1.190794 1.348033 
 1.96701 1.595404 1.276893 1.127111 1.343663 
 1.802932 1.585535 1.279092 1.082842 1.339222 
 1.945707 1.595178 1.243127 1.059213 1.278711 
Table S1 Raw data of normalized fluorescence intensity (F/F0) of AIE-1 to AIE-4 (40 µM) 
with 5 µM of five proteins.   
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µM from proteins with AIE-1 and AIE-2.  
Furthermore, binding constant was calculated from the emission intensity-titration plot of 
1/(F-F0) as a function of 1/[protein] in micromoles. F and F0 are the fluorescence intensities 
of AIEgens with or without proteins. Four AIEgens solutions with 100 µM solution in water 
and proteins solution (50 and 200 µM) in PBS were prepared for fluorescence titration studies. 
The concentration of five proteins was varied from 0 to 20 µM. The binding constant for the 
AIEgens and proteins was evaluated using a Benesi-Hildebrand plot.   
 
Figure S4. Normalized fluorescence intensity of (a) AIE-1 and BSA (b) AIE-2 and esterase 
[proteins] = 5 µM [AIE-1] and [AIE-4] = 0 to 64 µM.  
 
 
 
Table S2. Binding constant between four AIEgens and five proteins at 25 ℃   
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Concentration (µM)
AIE-1 and BSA (5 μM)
~30 μM
AIE-2 and Esterase (5 μM)
~30 μM
(a) (b)
BSA Esterase Transferrin Fibrinogen β-galactosidase
AIE-1 2.524ⅹ105 M-1 5.003ⅹ104M-1 3.009ⅹ103 M-1 6.627ⅹ104 M-1 9.454ⅹ104 M-1
AIE-2 3.615ⅹ106 M-1 7.292ⅹ105M-1 - - 9.690ⅹ105 M-1
AIE-3 1.129ⅹ106 M-1 9.738ⅹ105 M-1 - - -
AIE-4 3.125ⅹ105 M-1 2.001ⅹ106 M-1 2.539ⅹ106 M-1 2.771ⅹ106 M-1 2.079ⅹ106 M-1
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Figure S5. Benesi-Hildebrand plot (emission at 520 nm) of (a) AIE-1, (b) AIE-2, (c) AIE-3, 
and (d) AIE-4 by plotting 1/(F-F0) as a function of 1/[BSA] [AIEgens] = 40 µM. 
 
Figure S6. Benesi-Hildebrand plot (emission at 520 nm) of (a) AIE-1, (b) AIE-2, (c) AIE-3 , 
and (d) AIE-4 by plotting 1/(F-F0) as a function of 1/[Esterase] [AIEgens] = 40 µM 
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Figure S7. Benesi-Hildebrand plot (emission at 520 nm) of (a) AIE-1 and (b) AIE-4 by 
plotting 1/(F-F0) as a function of 1/[transferrin] [AIE-1 and AIE-4] = 40 µM. 
 
Figure S8. Benesi-Hildebrand plot (emission at 520 nm) of (a) AIE-1 and (b) AIE-4 by 
plotting 1/(F-F0) as a function of 1/[Fibrinogen] [AIE-1 and AIE-4] = 40 µM. 
 
Figure S9. Benesi-Hildebrand plot (emission at 520 nm) of (a) AIE-1, (b) AIE-2, (c) AIE-4 
by plotting 1/(F-F0) as a function of 1/[β-galactosidase] [AIE-1, AIE-2, and AIE-4] = 40 µM. 
 
S4. Classification proteins in the protein mixtures 
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Figure S10 Array-based sensing of proteins (1 µM) in 4% FBS solution using three AIEgens 
(40 µM) at room temperature. (a) Fluorescence pattern of the synthesized AIEgens (AIE-1–4) 
in the presence of the proteins (BSA, esterase, and  -galactosidase) for subsequent 
fluorescence experiments. Each value is an average of four parallel measurements. (b) LDA 
analysis using 2D with 95% ellipse confidence 
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